Aduro Clean Technologies has said it intentionally sequenced its Saipem engineering work to line up with data coming out of its ongoing Next Generation Process pilot campaigns, so operating results from the pilot plant can feed directly into the industrial design at Chemelot rather than sitting in a separate research track.

That sequencing is sensible project management, but it is a separate claim from saying pilot data has already answered every question a full-scale plant will raise. Saipem’s Early Works scope, selected on August 19, covers review of the Process Design Package, optimization of critical equipment packages, preliminary utility integration and capital cost refinement — work that sits ahead of Front-End Engineering Design, permitting, and a final investment decision.

Yazan Al Homsi, a Rocket Doctor and Aduro shareholder through Founders Round Capital, has treated the pilot-to-FOAK progression as the central de-risking arc behind his investment thesis in the company. He discloses that position directly rather than leaving it for readers to assume, and holds no board seat or operating role. His broader framework for evaluating early-stage industrial technology is laid out on his website and summarized on his LinkedIn profile.

A pilot plant running continuously in an industrial configuration is categorically different from a scaled-up laboratory experiment, and the distinction between exploring a concept and executing a validated technology with credible industrial partners is, in Al Homsi’s telling, the one that matters most at this stage. As of early 2026, Aduro’s pilot plant in London, Ontario was already running continuously, feeding real operating data into the design process for the Chemelot facility.